- Home
- ORIC vs NHP Comparison
ORIC vs NHP Comparison
Compare ORIC & NHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$9.33
Company Overview
Basic Information| Metric | ORIC | NHP |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.3M | 1.0B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORIC | NHP |
|---|---|---|
| Price | $9.33 | $15.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $19.73 | N/A |
| AVG Volume (30 Days) | 1.9M | ★ 2.0M |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $13.68 |
| 52 Week High | $14.93 | $15.39 |
Technical Indicators
Market Signals| Indicator | ORIC | NHP |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | N/A |
| Support Level | $7.60 | N/A |
| Resistance Level | $13.89 | N/A |
| Average True Range (ATR) | 0.53 | 0.00 |
| MACD | 0.21 | 0.00 |
| Stochastic Oscillator | 74.19 | 0.00 |
Price Performance
Historical Comparison ORIC
NHP
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.